Raymond James & Associates’s Genpact G Stock Holding History
Bought
Maintained
Sold
Other funds holding G
NIEF
FMI
Raymond James & Associates's G Position: Q3 2024 in Review
Raymond James & Associates reduced its Genpact (G) stake by 24% in Q3 2024, selling an estimated $1.55M and leaving 136,295 shares worth $5.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1615.
Raymond James & Associates first reported a position in G in Q2 2017 and has held it in 30 quarters since. The position peaked at $10.1M in Q1 2024. 386 funds tracked by Wall St. Rank hold G as of Q3 2024.
- Raymond James & Associates held 136,295 shares of Genpact worth $5.34M as of Q3 2024.
- Raymond James & Associates sold 42,853 Genpact shares in Q3 2024, an estimated $1.55M.
- Genpact made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1615 holding.
- Raymond James & Associates first reported a position in Genpact in Q2 2017 and has held it in 30 quarters since.
- Raymond James & Associates's Genpact position peaked at $10.1M in Q1 2024.
- 386 funds tracked by Wall St. Rank held Genpact as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.